OncoBriefs - Oncology Research News

UCSF Research Team Discovers New Villain Hiding in Pancreatic Tumors After Knocking Out Fibroblast's Primary Communication Channel

If CD19-targeted CAR T cells had an Instagram, their bio would read: "First FDA-approved gene therapy 💉 | Pediatric cancer fighter since 2017 | 90% remission rate energy | Currently beefing with solid tumors 😤 | DMs open for B-ALL referrals only." And honestly? That profile would be verified.

Somewhere deep inside your body, you were born with a loaded weapon pointed at cancer - and at your own brain. That's the unsettling takeaway from a new study published in Nature that reads like a medical thriller worthy of its own Netflix adaptation.

Breast cancer mortality in the United States has a reputation problem. On paper, it looks like a success story - deaths dropped by 26% between 2000 and 2019, sliding from 33.6 to 24.8 per 100,000 women. Headlines love that number. Politicians quote it. And if you're a white woman living in a...

Imagine you've just had surgery to remove a lung tumor. The surgeon gives you a thumbs up, the pathology report looks clean, and everyone's cautiously optimistic. But here's the uncomfortable truth that keeps oncologists up at night: somewhere between 30% and 55% of patients with early-stage...

Cancer research loves a good paradox, and here's one that should make you suspicious of every "immunotherapy breakthrough" headline you've read this year: we've spent decades trying to unleash the immune system against tumors, yet almost nobody thought to ask whether the immune system's own...

BULLETIN - University of Virginia, 2026: A research team has just announced the development of the first drug ever designed to target a protein called advillin - and it shrank brain tumors in mice without apparent side effects. The compound crosses the blood-brain barrier. It could potentially be...

KARLSRUHE, GERMANY - A team of researchers has reportedly convinced silicon-based nanoparticles to cosplay as enzymes, perform chemistry in water without any metals, and then - in a move nobody asked for but everyone needed - sneak into brain and skin cancer cells to activate a cancer-killing drug....

If tumors ever handed out report cards, most cancer biologists would still be getting an Incomplete in "How Cells Actually Spread." We've spent decades studying individual cancer cells sneaking off on their own little field trips through the body, only to discover that the real troublemakers are...

Watch closely. In one hand, we have imatinib—the drug that transformed chronic myeloid leukemia from a death sentence into a manageable condition back in 2001. Revolutionary stuff. In the other hand, we have the newer second-generation TKIs that promised even better results. And now, for the...

Chess grandmasters and oncologists have more in common than either group would probably admit. Both spend years memorizing openings, studying their opponent's every move, and agonizing over decisions where one wrong call can change everything. The difference? Chess engines surpassed human...

FIELD DISPATCH - SUBCUTANEOUS FRONT, SECTOR 7-BRAVO

Nobody puts "cancer diagnosis" on their pregnancy bingo card. Swollen ankles? Sure. Weird cravings at 2 AM? Expected. But a cervical cancer diagnosis at 10 weeks pregnant? That's the kind of plot twist nobody signed up for - and yet it happens to roughly 1.6 to 11.1 out of every 100,000 pregnant...

And what comes out might just change how we think about testing for treatable mutations.

1969: The first colonoscopy is performed, and humanity collectively agrees this is nobody's favorite Tuesday activity.

That's not the sound of a bug zapper on your porch. It's the sound of electric fields scrambling cancer cells in someone's pancreas - and the FDA just gave it a thumbs up.

That's the sound of a cell cycle clock - the molecular metronome that tells your cells when to divide. For most cells, it's a well-regulated symphony. But in the breast tissue of women under 40 with estrogen receptor-positive (ER+) cancer, that clock has apparently decided to go rogue, and it...